CoChat

Low absolute bioavailability of oral naloxone in healthy subjects

Smith, Kevin, Hopp, Michael, Mundin, Gill, Bond, Simon, Bailey, Paul, Woodward, Jo, Bell, David · 2012 · Int. Journal of Clinical Pharmacology and Therapeutics
Cited by 97

The DOI matches its Crossref record.

Abstract

OBJECTIVE: To determine the absolute bioavailability of naloxone from oral doses ranging from 5 mg to 120 mg. MATERIALS AND METHODS: In this open-label study, 28 healthy subjects received naloxone 1 mg (0.4 mg/ml) as an intravenous infusion (reference treatment), and the following oral doses as prolonged release (PR) naloxone tablets: 5 mg, 20 mg, 40 mg, 80 mg and 120 mg. The pharmacokinetic characteristics of 40 mg administered per rectum were also investigated. Each subject received five of the seven treatments as single doses with a 7 day washout between doses. Pharmacokinetic blood sampling and safety monitoring were performed for 24 h after the intravenous dose, and 72 h after the oral and rectal doses. RESULTS: The mean absolute bioavailability of naloxone from the orally administered PR tablets was very low, ranging from 0.9% for the 5 mg dose to 2% for the 40, 80 and 120 mg doses, based on AUC(t) values. The pharmacokinetics of naloxone were linear across the range of oral doses. Where AUC(inf) values were calculated, these confirmed the results based on AUC(t) values (mean absolute bioavailability ranging from 1.9% to 2.2% for the 20 mg to 120 mg oral doses). The absolute bioavailability of naloxone was higher following rectal administration compared with oral administration, but was still low at 15%. CONCLUSIONS: The mean oral absolute bioavailability of naloxone in this study was ≤ 2% at doses ranging from 5 mg to 120 mg.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5414/cp201646

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 97

Metadata

Authors
Smith, K., Hopp, M., Mundin, G., Bond, S., Bailey, P., Woodward, J., & Bell, D.
Venue
Int. Journal of Clinical Pharmacology and Therapeutics
Published
2012-05-01
Volume
50
Issue
05
Pages
360-367
ISSN
0946-1965 (ISSN-L)
OpenAlex
W2330539082
Cited by
97
References
0
FWCI
9.84
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Low absolute bioavailability of oral naloxone in healthy subjects. https://app.cochat.ai/papers/10.5414/cp201646
The paper
Smith, K., Hopp, M., Mundin, G., Bond, S., Bailey, P., Woodward, J., & Bell, D. (2012). Low absolute bioavailability of oral naloxone in healthy subjects. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp201646

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.